These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12003109)

  • 1. The San Francisco centralized intake unit: a description of participants and service episodes.
    Woods WJ; Klingemann SD; Guydish JR
    J Psychoactive Drugs; 2002; 34(1):17-24. PubMed ID: 12003109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women are less likely to be admitted to substance abuse treatment within 30 days of assessment.
    Arfken CL; Borisova N; Klein C; di Menza S; Schuster CR
    J Psychoactive Drugs; 2002; 34(1):33-8. PubMed ID: 12003111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of centralized intake on drug and alcohol treatment placement decisions.
    Scott CK; Foss MA
    J Psychoactive Drugs; 2002; 34(1):7-15. PubMed ID: 12003116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of treatment history and centralized intake on drug treatment outcomes.
    Sears C; Davis T; Guydish J
    J Psychoactive Drugs; 2002; 34(1):87-95. PubMed ID: 12003118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug abuse treatment on demand in San Francisco: preliminary findings.
    Guydish J; Moore L; Gleghorn A; Davis T; Sears C; Harcourt J
    J Psychoactive Drugs; 2000; 32(4):363-70. PubMed ID: 11210197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varieties of centralized intake: the Portland Target Cities Project experience.
    Barron N; McFarland BH; McCamant L
    J Psychoactive Drugs; 2002; 34(1):75-86. PubMed ID: 12003117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of centralized intake on case management services.
    Scott CK; Sherman RE; Foss MA; Godley M; Hristova L
    J Psychoactive Drugs; 2002; 34(1):51-7. PubMed ID: 12003113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does centralized intake improve drug abuse treatment outcomes?
    Guydish J; Woods WJ; Davis T; Bostrom A; Frazier Y
    J Subst Abuse Treat; 2001 Jun; 20(4):265-73; discussion 275-6. PubMed ID: 11672641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction effects of treatment setting and client characteristics on retention and completion.
    Klein C; di Menza S; Arfken C; Schuster CR
    J Psychoactive Drugs; 2002; 34(1):39-50. PubMed ID: 12003112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to drug abuse treatment under Treatment on Demand policy in San Francisco.
    Sorensen JL; Guydish J; Zilavy P; Davis TB; Gleghorn A; Jacoby M; Sears C
    Am J Drug Alcohol Abuse; 2007; 33(2):227-36. PubMed ID: 17497545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the effects of San Francisco's Treatment on Demand Initiative on a publicly-funded substance abuse treatment system: a time series analysis.
    Sears C; Davis T; Guydish J; Gleghorn A
    J Psychoactive Drugs; 2009 Sep; 41(3):297-304. PubMed ID: 19999683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of brief interventions and brief treatment on admissions to chemical dependency treatment.
    Krupski A; Sears JM; Joesch JM; Estee S; He L; Dunn C; Huber A; Roy-Byrne P; Ries R
    Drug Alcohol Depend; 2010 Jul; 110(1-2):126-36. PubMed ID: 20347234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of California's Proposition 36 on the drug treatment system: treatment capacity and displacement.
    Hser YI; Teruya C; Brown AH; Huang D; Evans E; Anglin MD
    Am J Public Health; 2007 Jan; 97(1):104-9. PubMed ID: 17138930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health parity legislation, cost-sharing and substance-abuse treatment admissions.
    Dave D; Mukerjee S
    Health Econ; 2011 Feb; 20(2):161-83. PubMed ID: 20029912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Documenting changes in the delivery of substance abuse services: the Status of the "100 best treatment centers for alcoholism and drug abuse" of 1988.
    Macmaster SA; Holleran LK; Chantus D; Kostyk L
    J Health Soc Policy; 2005; 20(3):67-77. PubMed ID: 16236679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of a consultation center and crisis intervention in addressing psychiatric disorders in the perinatal period].
    Vaiva G; Maron M; Chapoy V; Thomas P; Codaccioni X; Goudemand M
    Encephale; 2002; 28(1):71-6. PubMed ID: 11963346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of full vs. partial continuum of care in the treatment of publicly funded substance abusers in Washington State.
    McKay JR; Donovan DM; McLellan T; Krupski A; Hansten M; Stark KD; Geary K; Cecere J
    Am J Drug Alcohol Abuse; 2002; 28(2):307-38. PubMed ID: 12014818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled-release oxycodone admissions in public and private substance abuse treatment: associations with organizational characteristics.
    Knudsen HK; Ducharme LJ; Roman PM
    J Addict Dis; 2007; 26(1):41-50. PubMed ID: 17439867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.